Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022
| Contributor Information
Swipe to advance
Image from Wikimedia Commons | EMAHkempny. [Creative Commons Attribution-Share Alike 4.0 International License (CC by-SA 4.0).]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
The above image shows dilation of superficial veins in an individual with superior vena cava (SCV) syndrome, which occurs when blood flow through the SVC is partially or completely obstructed. This obstruction often results from a malignant mass compressing the SVC.
Medical emergencies in patients with cancer can arise as complications of the disease itself and/or the treatment for the tumor(s). It is critical that clinicians across all specialties not only be aware of, and quickly recognize, the potential oncologic emergencies that may occur in these patients, but also know how to provide urgent and effective care to manage such clinical crises.[1,2]
An electron micrograph of a cell undergoing apoptosis is shown. Adapted image from the National Cancer Institute | Susan Arnold. [Public domain.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Tumor Lysis Syndrome
Hematologic cancers, fast-growing and bulky tumors, and neoplasms that are highly responsive to treatment can cause tumor lysis syndrome (TLS), a constellation of severe metabolic disturbances, after the initiation of chemotherapy or radiation.[1,2]
As tumor cells die and their cell walls break down (shown), they release potassium, phosphorus, proteins, and nucleic acids. The nucleic acids further break down into uric acid.
Hyperphosphatemia caused by TLS can result in hypocalcemia, tetany, seizures, and cardiac dysrhythmias.[3]
Hyperuricemia can lead to in renal failure, which can compound TLS-associated hyperkalemia; this, in turn, can cause cardiac dysrhythmias and death.[4]
An electrocardiogram (ECG) depicting combined hyperkalemia and hypocalcemia is shown. Image from Wikimedia Commons | Jer5150. [CC by-SA 3.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Prevention of TLS is the best way to reduce mortality from this condition; however, if TLS develops, treatment should include aggressive fluid hydration. Diuretics may be used to increase urine output and potassium excretion. Rasburicase, a DNA recombinant urate oxidase enzyme, may be used to reduce the serum concentration of uric acid.
If hyperkalemia is suspected, the patient should remain on cardiac monitoring and an ECG should be obtained. Calcium should be administered to prevent dysrhythmias. In severe cases, patients may require dialysis.[4]
Image from Wikimedia Commons | Mikael Häggström. [CC0 1.0 Universal (CC0 1.0). Public Domain Dedication.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Hypercalcemia of Malignancy
The most common cause of hypercalcemia of malignancy is the secretion of parathyroid hormone (PTH)–related protein by the tumor; this protein mimics PTH and leads to bone resorption and decreased renal calcium excretion. Symptoms/signs can include nausea, lethargy, and confusion.[4]
Clinicians should calculate an ionized serum calcium level to accurately assess the severity of the patient's hypercalcemia. Intravenous (IV) hydration is the initial treatment for hypercalcemia, and IV bisphosphonates are the next line of therapy. Review the patient's medication list: Some medications (eg, thiazide diuretics) can increase calcium reabsorption. Dialysis may be required if the patient cannot tolerate large volumes of IV hydration.[4]
Neutrophils (arrows) in a peripheral blood smear are shown. Image from Wikimedia Commons. [CC by-SA 3.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Neutropenic Fever
Neutropenic fever, or febrile neutropenia, can be defined as a condition in which a patient with neutropenia (absolute neutrophil count [ANC] <1500 cells/µL) has an oral temperature above 38°C (100.4°F) for longer than 1 hour. Patients on cytotoxic chemotherapies and those with hematologic cancers are at highest risk for this condition. Avoid measuring the rectal temperature in cases of neutropenic fever, since use of a rectal thermometer puts the patient, who is immunocompromised, at increased risk for invasion of the mucosa by gut-colonizing organisms.[5] The risks for infection are also increased by the presence of indwelling ports. Early IV antimicrobial treatment reduces mortality in patients with neutropenic fever. Antibiotics should never be delayed for blood or culture draws.
Images of typhlitis in a postchemotherapy lymphoma patient are shown. Images from Rizzo S, Bellomi M. Ecancermedicalscience. 2010;4:193. [Open access.] PMID: 22276041, PMCID: PMC3234017. [CC Attribution 2.0 Generic (CC by 2.0).]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Typhlitis
Typhlitis, also known as neutropenic enterocolitis, starts with inflammation of the ileocecum and progresses to necrosis. It is most commonly seen in patients with leukemia or lymphoma. Mortality in untreated individuals approaches 100%. Patients may present to the emergency department with fever, diarrhea, melena, and abdominal pain.[6] Severe neutropenia predisposes patients to this life-threatening condition.
Obtain early computed tomography (CT) scans for prompt diagnosis. CT scan findings may include bowel wall thickening (shown), fat stranding (shown), pneumatosis intestinalis, or ileus. Treatment includes administering IV fluids and broad-spectrum antibiotics, as well as bowel rest. If bowel wall perforation, severe sepsis, or clinical worsening occurs despite appropriate treatment, obtain emergent surgical consultation.[7]
Image from Wikimedia Commons | James Heilman, MD. [CC by-SA 3.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Hyperviscosity Syndrome
The above CT scan demonstrates bowel ischemia, one cause of which can be hyperviscosity syndrome; the small bowel has acquired dilated loops and thickened walls (arrow).
Hyperviscosity syndrome occurs when elevated gamma globulins in the bloodstream increase the viscosity of circulating blood.[8] Patients with Waldenström macroglobulinemia or multiple myeloma are most commonly affected.[2]
Mucocutaneous bleeding, such as epistaxis, is a frequent presenting sign. Patients may also complain of visual changes.[2] Higher viscosity can lead to seizures, stroke, and coma. Bowel ischemia (above) may develop. Heart failure can occur due to the expansion of circulating plasma volume.[8] Treatment is emergent plasmapheresis.[9]
A chest CT scan with contrast that reveals narrowing of the SVC is shown. Image from Senthilvel E, Papadakis A, Jain V, Bruner J. Cases J. 2009;2:6463. [Open access.] PMID: 19829810, PMCID: PMC2740218. [CC Attribution 3.0 Unported (CC by 3.0).]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Superior Vena Cava Syndrome
SVC syndrome occurs in patients with cancer when a mass compresses the SVC, compromising the return of blood to the heart. Most cases result from malignancy, specifically lung cancer and lymphoma; however, thrombosis and postradiation fibrosis are also potential causes.[1,10]
Shortness of breath and facial swelling are the most frequent manifestations among presenting signs and symptoms. Airway compression, laryngeal edema, pleural effusion, and cerebral edema may develop. Some patients may be less symptomatic if the SVC is compressed over time and they develop collateral blood flow. If no collateral blood flow is present and the SVC compression develops quickly, severe airway edema requiring emergent airway management may develop.[10]
Facial plethora and neck vein distention are shown in the left image. A chest x-ray demonstrating signs of a mass is displayed on the right. Images from Ferencga (left) and James Heilman, MD (right), both via Wikimedia Commons. [Both CC by-SA 3.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Physical examination findings in patients with SVC syndrome may include facial plethora and neck vein distention. Obtaining a chest x-ray is an appropriate first step in making the diagnosis, as most of the images will be abnormal and will show signs of a mass.[10] However, chest CT scanning with contrast is the ideal imaging test (see the image on the previous slide).
As a temporizing measure, an interventional radiologist can place a stent for symptomatic relief. Chemotherapy and radiation therapy are used as definitive treatments, although long-term survival is generally poor.[10]
Image of mucositis from Gussgard AM, Hope AJ, Jokstad A, Tenenbaum H, Wood R. PLoS One. 2014;9(3):e91733. [Open access.] PMID: 24614512, PMCID: PMC3948915. [CC by 4.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Mucositis
Chemotherapy and/or radiotherapy have many painful side effects, including mucositis. In severe cases, patients can develop ulcers that reach the submucosa. Although mucositis most often results from cancer treatment, clinicians should be aware that opportunistic infections can also cause the condition. In addition, mucositis can be the presenting sign of graft-versus-host disease (GvHD). While oral lesions are the easiest to diagnose, mucositis can affect any part of the gastrointestinal (GI) tract.[11]
Image from Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sunpaweravong P. Head Neck Oncol. 2011;3:30. [Open access.] PMID: 21639934, PMCID: PMC3123312. [CC by 2.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Severe mucositis with a confluent pseudomembranous mucosa in a patient undergoing chemotherapy for nasopharyngeal carcinoma is shown.
Symptomatically, mucositis causes severe pain, leading to reduced oral intake. The breakdown of the mucosal barrier (shown) puts patients at high risk for secondary infections and even bacteremia.[11]
Ice chips, saline rinses, topical lidocaine, and topical nystatin have all been used with varying degrees of improvement.[12] IV analgesia is often required for pain control.
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Graft-Versus-Host Disease
A maculopapular rash in a patient with GvHD is shown in the image on the left. The endoscopic image on the right reveals edematous, red, friable GI mucosa in another patient with GvHD.
GvHD occurs when immune cells from transplanted tissue attack the recipient's tissues. This condition most commonly arises after stem cell transplantation, but it also can occur after solid organ transplantation.[13] Acute GvHD is defined as occurring within 100 days of transplant.[13] The skin is most frequently affected and usually presents with a maculopapular rash.
At its worst, GvHD can be similar in appearance to toxic epidermal necrolysis, with bullae, mucous membrane desquamation, and extensive skin involvement. If present, rash involving the palms and soles and GI symptoms (eg, watery diarrhea, hyperbilirubinemia) make GvHD more likely than toxic epidermal necrolysis. GvHD should also be considered in patients with culture-negative fevers.[14]
Images from Gunes G, Demiroglu H, Goker H, et al. Case Rep Hematol. 2015;2015:692175. [Open access.] PMID: 26613052, PMCID: PMC4646988. [CC by 3.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
The thickened skin of a patient with steroid-refractory cutaneous GvHD is shown. At different periods, treatment was attempted with methylprednisolone, cyclosporine A, tacrolimus, photo sensitizer 8-methoxypsoralen ultraviolet A (PUVA), photopheresis, and thalidomide—all with limited effect.
From Wikimedia Commons | Wutsje. [CC by-SA 3.0]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Pain
Used for palliative sedation in terminal cancer, the above infusion pump reservoir contains midazolam and morphine.
Many patients with cancer will suffer pain at some point. Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) should be considered first-line treatment for mild pain in cancer. NSAIDs work synergistically with opioids and can be particularly useful for treating pain from connective tissues, joints, and bones. Hydrocodone, oxycodone, codeine, and tramadol are second-line treatments of mild cancer-related pain.[15]
A generic fentanyl transdermal patch is shown. Image from Wikimedia Commons | DanielTahar. [CC by-SA 4.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Moderate to severe pain in patients with cancer can be treated with morphine, hydromorphone, methadone, or fentanyl. The dosing can be titrated without a ceiling to achieve analgesia. Morphine is excreted renally; therefore, clinicians should use cautious dosing in patients with evidence of reduced creatinine clearance. Hydromorphone is metabolized hepatically and thus may not be appropriate in patients with liver dysfunction.
Methadone has the benefit of a long half-life; however, it can cause significant QT prolongation and subsequent torsade de pointes. Fentanyl is lipophilic and can be absorbed across the skin and mucosa. Although the analgesic effect of fentanyl is equivalent to that of morphine, the side effects of drowsiness and constipation associated with morphine are less common with fentanyl. Transdermal fentanyl titration can be dangerous and should not be started in the emergency department.[15]
Adapted image from Faugeras L, Cantineau G, Daisne JF, Gustin T, D'hondt L. BMC Res Notes. 2015;8:41. [Open access.] PMID: 25889352, PMCID: PMC4340695. [CC by 4.0.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Adjuvant analgesia
The above image demonstrates spinal cord edema (yellow arrow) due to intramedullary metastasis (white arrow) of cholangiocarcinoma.
Some adjuvant analgesics have been studied in patients with cancer, with mixed results.[15] Tricyclic antidepressants for the treatment of neuropathic pain have had varying effects in studies. In elderly patients, the potential benefits of these medications are outweighed by the risks of hypotension, cardiac dysrhythmias, and delirium.
Corticosteroids can be effective in the treatment of bone pain from liver metastases. Cerebral or spinal cord edema (above) due to cancer lesions can also improve with steroid administration.
Cannabinoids are shown. Image from Public Domain Pictures | Circe Denyer. [CC0 1.0 Universal (CC0 1.0). Public Domain Dedication.]
8 Medical Oncologic Emergencies You Need to Know
Nicole Cimino-Fiallos, MD, FACEP, FAAEM | October 7, 2022 | Contributor Information
Gabapentin has shown efficacy in treating neuropathic pain, but the patient's creatinine clearance must be considered prior to administration. Gabapentin must be titrated slowly and can cause decreased mental status. IV or subcutaneous lidocaine can also be considered for pain relief, but this agent is not appropriate for patients with cardiac conditions.[15]
Cannabinoids have been used to treat pain that is not well controlled with opioid therapy. Although some studies have shown improvement in pain control with cannabinoid use, such treatment is not considered first line, and it appears to be most useful in combination with other pain medication regimens.[15]
Commenting is limited to medical professionals. To comment please Log-in.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Close
Contributor Information
Author
Nicole Cimino-Fiallos, MD, FACEP, FAAEM
Emergency Medicine Specialist
US Acute Care Solutions;
Assistant Medical Director
Emergency Department
Meritus Medical Center
Hagerstown, MD
Disclosure: Nicole Cimino-Fiallos, MD, FACEP, FAAEM, has disclosed no relevant financial relationships.
Editor
Olivia Wong, DO
Section Editor
Medscape Drugs & Diseases
New York, NY
Disclosure: Olivia Wong, DO, has disclosed no relevant financial relationships.
Close
References
Higdon ML, Atkinson CJ, Lawrence KV. Oncologic emergencies: recognition and initial management. Am Fam Physician. 2018 Jun 1;97(11):741-8. PMID: 30215936
Klemencic S, Perkins J. Diagnosis and management of oncologic emergencies. West J Emerg Med. 2019 Mar;20(2):316-22. PMID: 30881552
Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011 May 12;364(19):1844-54. PMID: 21561350 [Full text].
Pi J, Kang Y, Smith M, Earl M, Norigian Z, McBride A. A review in the treatment of oncologic emergencies. J Oncol Pharm Pract. 2016 Aug;22(4):625-38. PMID: 26447101
Sachak T, Arnold MA, Naini BV, et al. Neutropenic enterocolitis: new insights into a deadly entity. Am J Surg Pathol. 2015 Dec;39(12):1635-42. PMID: 26414225
Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013 Mar;56(5):711-7. PMID: 23196957
Geha RM, Tierney LM, Jr. Blood is thicker: hyperviscosity syndrome. Am J Med. 2018 Aug;131(8):916-7. PMID: 29577910
Morin S, Grateau A, Reuter D, et al. Management of superior vena cava syndrome in critically ill cancer patients. Support Care Cancer. 2018 Feb;26(2):521-8. PMID: 28836006
Jensen SB, Peterson DE. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. J Oral Pathol Med. 2014 Feb;43(2):81-90. PMID: 24261541
Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012 Apr 28;18(16):1851-60. PMID: 22563164
Funke VA, Moreira MC, Vigorito AC. Acute and chronic graft-versus-host disease after hematopoietic stem cell transplantation. Rev Assoc Med Bras (1992) . 2016 Oct;62 suppl 1:44-50. PMID: 27982319
Dignan FL, Clark A, Amrolia P, et al, for the Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Diagnosis and management of acute graft-versus-host disease. Br J Haematol. 2012 Jul;158(1):30-45. PMID: 22533831
Prommer EE. Pharmacological management of cancer-related pain. Cancer Control. 2015 Oct;22(4):412-25. PMID: 26678968
Please do not use this form to submit personal or patient medical information or to report adverse drug events. You are encouraged to report adverse drug event information to the FDA.
Comments